ABIOMED's net profit under GAAP for 6 months of fiscal 2021 was $106,801 million, up 4.7% from $101,994 million in the previous year. Revenue decreased by 9.2% to $374.614 million, against $412.64 million a year earlier.
ABIOMED's net profit under GAAP for 6 months of fiscal 2021 was $106,801 million, up 4.7% from $101,994 million in the previous year. Revenue decreased by 9.2% to $374.614 million, against $412.64 million a year earlier. 
investors.abiomed.com
English (US) 